Frontlight ResearchEarly access
Trial site
BHI of Omsk region "Clinical Oncology Dispensary"
- 6running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Lung cancer2 trials
- Ulcerative colitis2 trials
- Childhood cancers1 trial
- Crohn's disease1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- and 1 more
- Phase
- Phase 38 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Pfizer2 trials
- Eisai Inc.1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Guerbet1 trial
- and 5 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026